BRKR

Bruker Corporation

Price

$39.90

return (12m)

p/e

-767.47

p/bv

3.56

DIVIDEND YIELD

0.34%

BRKR price

Bruker

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BRKR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BRKR

Valuation

P/E

-767.47

Sector -2.34

Industry 11.10

P/BV

3.56

Sector 2.17

Industry 3.33

P/Revenue (PSR)

2.57

Sector 2.00

Industry 1.71

EV/EBITDA

112.90

Sector -23.69

Industry -398.52

EV/EBIT

305.93

Sector -36.60

Industry -80.73

P/EBITDA

29.06

Sector -0.10

Industry 8.30

P/EBIT

113.84

Sector -2.08

Industry 5.69

P/Total Assets

1.45

Sector 1.18

Industry 1.57

P/Net Current Assets

-5.84

Sector -10.91

Industry -3.38

P/Working Capital

11.89

Sector 0.09

Industry 10.51

EPS

-0.08

Sector -0.93

Industry 1.10

BVPS

16.47

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

45.29%

Sector 44.28%

Industry 29.23%

EBITDA Margin

11.22%

Sector -291.45%

Industry 4.29%

EBIT Margin

4.14%

Sector -195.44%

Industry 1.44%

Operating Margin

6.06%

Sector -25.72%

Industry 2.16%

Net Profit Margins

-0.34%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.13

Sector 0.12

Industry 0.27

Profitability

ROE

-0.46%

Sector -34.71%

Industry 6.97%

ROA

-0.19%

Sector -28.76%

Industry 2.97%

ROIC

2.30%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.34%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.54%

Debt

Current Ratio

1.55

Sector 1.87

Industry 1.51

Net Debt / EBITDA

16.55

Sector -2.18

Industry -1.68

Net Debt / EBIT

44.85

Sector -0.74

Industry -7.00

Net Debt / Equity

0.61

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.66

Sector -0.64

Industry 0.35

Equity/Assets

0.41

Sector 0.43

Industry 0.46

Liabilities/Assets

0.59

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

7.42%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BRKR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BRKR Bruker Corporation	$39.90	3.47%	0.34%	-767.47	3.56	-0.46%	-0.34%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BRKR Historical Dividends

current DY: 0.34%

5-year average DY: 0.30%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/23/2026	04/07/2026	0.05000000
Dividends	12/08/2025	01/02/2026	0.05000000
Dividends	09/23/2025	10/03/2025	0.05000000
Dividends	06/16/2025	06/27/2025	0.05000000
Dividends	03/17/2025	03/28/2025	0.05000000
Dividends	12/02/2024	12/16/2024	0.05000000
Dividends	09/02/2024	09/16/2024	0.05000000
Dividends	06/03/2024	06/17/2024	0.05000000
Dividends	03/01/2024	03/15/2024	0.05000000
Dividends	12/01/2023	12/15/2023	0.05000000
Dividends	09/01/2023	09/15/2023	0.05000000
Dividends	06/01/2023	06/16/2023	0.05000000
Dividends	03/01/2023	03/17/2023	0.05000000
Dividends	12/01/2022	12/16/2022	0.05000000
Dividends	09/01/2022	09/16/2022	0.05000000
Dividends	06/01/2022	06/17/2022	0.05000000
Dividends	03/01/2022	03/18/2022	0.05000000
Dividends	12/01/2021	12/17/2021	0.04000000
Dividends	09/01/2021	09/17/2021	0.04000000
Dividends	06/01/2021	06/18/2021	0.04000000
Dividends	03/05/2021	03/19/2021	0.04000000
Dividends	12/01/2020	12/18/2020	0.04000000
Dividends	09/01/2020	09/18/2020	0.04000000
Dividends	06/01/2020	06/19/2020	0.04000000
Dividends	03/09/2020	03/20/2020	0.04000000
Dividends	12/02/2019	12/20/2019	0.04000000
Dividends	09/03/2019	09/20/2019	0.04000000
Dividends	06/03/2019	06/21/2019	0.04000000
Dividends	03/05/2019	03/22/2019	0.04000000
Dividends	12/03/2018	12/21/2018	0.04000000
Dividends	09/04/2018	09/21/2018	0.04000000
Dividends	06/04/2018	06/22/2018	0.04000000
Dividends	03/06/2018	03/23/2018	0.04000000
Dividends	12/04/2017	12/22/2017	0.04000000
Dividends	09/05/2017	09/22/2017	0.04000000
Dividends	06/05/2017	06/23/2017	0.04000000
Dividends	03/08/2017	03/24/2017	0.04000000
Dividends	12/05/2016	12/23/2016	0.04000000
Dividends	09/06/2016	09/23/2016	0.04000000
Dividends	06/06/2016	06/24/2016	0.04000000
Dividends	03/04/2016	03/24/2016	0.04000000

ABOUT Bruker

Bruker Corporation

Average Investor10 user rating

4.0 (0 people)

States of America

35 years

Founded: 1991

2000

Time since IPO - 26 years

7.400

Employees

Bruker Corporation (States of America) is listed on the Nasdaq and has a market capitalization of $8.90 billion, with shareholders equity totaling $2.50 billion.

The company employs approximately 7.400 people and operates in the Saúde sector, within the Ferramentas e Serviços de Ciências da Vida industry.

Over the past 12 months, Bruker Corporation reported $3.46 billion in revenue, generating net income of $-11.60 million.

Key financial metrics include a P/E ratio of -767.47, a price-to-book (P/B) ratio of 3.56, and a trailing twelve-month dividend yield of 0.34%.

The company trades under the ticker BRKR.

Market cap

$8.90 billion

Net worth

$2.50 billion

$2,502,800,000.00

Assets

$6.13 billion

$6,130,700,000.00

Total Shares Outstanding

152.00 million

152,000,000

Average Daily Trading Volume

$2.59 million

$2,592,052.00

Sector

Saúde

Industry

Ferramentas e Serviços de Ciências da Vida

BRKR

BRKR revenue and profits

Financial Results BRKR

DRAG THE FRAME TO SEE MORE DATA

BRKR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56